P23 PREDICTION OF TOTAL AND CAUSE-SPECIFIC MORTALITY INCIDENCE AS WELL AS CARDIOVASCULAR MORBIDITY BY USE OF NON-INVASIVE MEASUREMENT OF CAROTID- FEMORAL PULSE WAVE VELOCITY AS A MEASURE OF ARTERIAL STIFFNESS

2017 ◽  
Vol 20 (C) ◽  
pp. 100
Author(s):  
Peter Nilsson ◽  
Mikael Gottsäter ◽  
Abd al-Hakim Fatehali
2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e224
Author(s):  
C. Magistri ◽  
F.U.S. Mattace Raso ◽  
F. Battista ◽  
F. Anastasio ◽  
G. Pucci

2009 ◽  
Vol 3 (2) ◽  
pp. 79 ◽  
Author(s):  
Patrick Segers ◽  
Jan Kips ◽  
Bram Trachet ◽  
Abigail Swillens ◽  
Sebastian Vermeersch ◽  
...  

2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e199
Author(s):  
A. Grillo ◽  
F. Moretti ◽  
M. Rovina ◽  
C. Baldi ◽  
L. Salvi ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
N Georgieva ◽  
A Borizanova-Petkova ◽  
E Kinova ◽  
A Goudev

Abstract Background Non-invasive measurements of 24 h ambulatory central aortic systolic pressure (24hCASP) is now feasible method than single measurement of CASP. There is growing interest in CASP as cardiovascular risk marker beyond conventional brachial blood pressure (BP). Pulse wave velocity estimates arterial stiffness, whereas CASP is representative of the BP in major organs. Purpose To evaluate non- invasive parameters for arterial stiffness using oscillometric method and to compare 24hCASP with single measurement of CASP in well-controlled hypertensive patients to detect target organ damage (TOD). Methods A total 95 patients (57±14 years) with hypertension, were separated in two groups: 22 patients with normal EA/Ees ratio (Arterial elastance (EA) and ventricular elastance (Ees)) and 73 hypertensive patients with decrease EA/Ees ratio, marker for ventriculo-arterial coupling. EA and Ees were calculated as and – systolic pressure/stroke volume and end-systolic pressure/end-systolic volume. Parameters for arterial stiffness – 24hCASP, ambulatory central systolic pressure (CASP), 24-hour pulse wave velocity (PWV24h) and ambulatory PWV were measured non-invasively with oscillometric method by Mobil-O-graph PWA. Results Statistically significant differences in parameters of vascular stiffness were found in patients with normal ventriculo-arterial coupling in comparison with disturbed EA/Ees: 24hCASP (107.64±9.19 vs. 116.64±16.7 mm Hg, p=0.02), CAP (117.45±9.26 vs. 128.42±16.15 mm Hg, p<0.0001). There were no statistically significant differences in PWV and PWV24h. Multiple regression analysis demonstrated that CAP (B=−0.264 p=0.003; 95% CI: −0.003–0.014) is independent predictor of TOD in hypertensive patients, than 24 hour central aortic pressure. Conclusion There is no superiority of 24hCASP than single measurment of CASP. CASP could predict preclinical damage and cardiovascular outcome. Funding Acknowledgement Type of funding source: None


Vascular ◽  
2012 ◽  
Vol 20 (6) ◽  
pp. 342-349 ◽  
Author(s):  
Jennifer M Davies ◽  
Marc A Bailey ◽  
Kathryn J Griffin ◽  
D Julian A Scott

Pulse wave velocity (PWV) is a known indicator of arterial stiffness and cardiovascular risk. We critically evaluated the evidence supporting the four main non-invasive devices available to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. PubMed and Medline databases (1960–2011) were searched to identify studies reporting carotid–femoral PWV in humans using one or more of the four devices. Of the 183 articles retrieved, 43 met inclusion criteria. The Arteriograph device demonstrated least variance but had poor agreement with the other devices. Undisputable reference values for PWV need to be established and internationally agreed, and a standardized method for superficial distance measurement generated to reduce variability. Further studies comparing all four devices with invasive assessment are necessary.


Sign in / Sign up

Export Citation Format

Share Document